Year: 2022
Type: review
Abstract: Alzheimer's disease (AD), due to its spread, has become a global health priority, and is characterized by senile dementia and progressive disability. The main cause of AD and other neurodegenerations (Huntington, Parkinson, Amyotrophic Lateral Sclerosis) are aggregated protein accumulation and oxidative damage. Recent research on secondary metabolites of plants such as polyphenols demonstrated that they may slow the progression of AD. The flavonoids' mechanism of action in AD involved the inhibition of acetylcholinesterase, butyrylcholinesterase, Tau protein aggregation, β-secretase, oxidative stress, inflammation, and apoptosis through modulation of signaling pathways which are implicated in cognitive and neuroprotective functions, such as ERK, PI3-kinase/Akt, NFKB, MAPKs, and endogenous antioxidant enzymatic systems. This review focuses on flavonoids and their role in AD, in terms of therapeutic potentiality for human health, antioxidant potential, and specific AD molecular targets.
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, flavonoids, neuroprotection, acetylcholinesterase inhibition, butyrylcholinesterase, tau aggregation, beta-secretase, oxidative stress, neuroinflammation, apoptosis, PI3K/Akt signaling, MAPK signaling, NF-κB, antioxidant enzymes, plant secondary metabolites, neurodegenerative diseases
Open Access status: gold
Estimated APC paid: $2,408
OpenAlex ID: W4311004257
